Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: A Cross-Sectional Study

Jasuja, Guneet K.; Rose, Adam J.

doi:10.1007/s11606-017-4113-z

Cited by 8 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most participants reported no negative side-effects or concerns after taking PT, and most participants would recommend PT to friends and family members. Further, findings mirror the general trends and prescribing patterns found in the U.S. PT literature [2,7,13,23,30,31,32,33,34].…”

Section: Discussionsupporting

confidence: 76%

“…While diagnostic criteria for classical hypogonadism seem clear [13,36], diagnosis of LOH varies by specialist, lab, medical society, and region [13,16,17,24,35,37]. Furthermore, much of the expansion of U.S. PT sales has been driven by off-label indications such as LOH or treatment of androgen levels without a reported diagnosis [7,31].…”

Section: Discussionmentioning

confidence: 99%

“…As of 2016, the U.S. represented more than 80% of global PT prescription sales [1,6]. While the rate of new PT prescriptions has dropped in the past 5 years, the U.S. continues to lead in the global PT market share [5,6,7].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Sex, Energy, Well-Being and Low Testosterone: An Exploratory Survey of U.S. Men’s Experiences on Prescription Testosterone

Straftis

Gray

2019

IJERPH

View full text Add to dashboard Cite

Prescription testosterone sales in the United States have skyrocketed in the last two decades due to an aging population, direct-to-consumer advertising, and prescriber views of the benefits and risks to testosterone, among other factors. However, few studies have attempted to directly examine patient experiences on prescription testosterone therapy. The present exploratory study involved an online self-report survey of U.S. testosterone patients who were at least 21 years of age. The primary focus was on patient perspectives concerning motivations leading to the initiation of testosterone therapy and the perceived effects of treatment. Responses to open-ended questions drew upon a coding scheme incorporating both inductive and deductive approaches, influenced by the clinical, male life history theory, and behavioral endocrinology literature. Results indicated that the most frequent reasons men gave for taking prescription testosterone were low testosterone (37.1%), well-being (35.2%), energy (28.7%), libido (21.9%), and social energy (19.4%); older men claimed libido as a motivation for testosterone initiation more frequently than younger men (p < 0.001). Men most frequently claimed testosterone improved their energy (52.3%), libido (41.9%), and muscle (28.5%). Results are interpreted in the context of medical, life history theoretical and behavioral endocrinology approaches, including an emphasis on sex and energy.

show abstract